These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2078707)

  • 21. Retrospective testing of an insulin advisory system.
    Svacina S; Haas T; Hovorka R
    Sb Lek; 1995; 96(4):307-12. PubMed ID: 8711374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neural network modeling and control of type 1 diabetes mellitus.
    El-Jabali AK
    Bioprocess Biosyst Eng; 2005 Apr; 27(2):75-9. PubMed ID: 15578231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Glucose-controlled insulin infusion systems (GCIIS, artificial pancreas) in therapy of diabetes mellitus and organic hyperinsulinism].
    Sailer D
    Verh Dtsch Ges Inn Med; 1987; 93():309-12. PubMed ID: 3442106
    [No Abstract]   [Full Text] [Related]  

  • 24. Not the artificial beta cell algorithms but their parameter values are important in automated glucose control of insulin-dependent diabetes.
    Fischer U; Jutzi E; Albrecht G; Abel P; Salzsieder E; Freyse EJ; Detscheff W; Lemke K
    Trans Am Soc Artif Intern Organs; 1983; 29():488-91. PubMed ID: 6673274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of the Biostator in optimizing insulin treatment (preliminary communication)].
    Kábrt J; Masek Z; Páv J
    Vnitr Lek; 1985 Sep; 31(9):870-6. PubMed ID: 4049764
    [No Abstract]   [Full Text] [Related]  

  • 26. [Diabetes mellitus in the year 1982].
    van Ballegooie E
    Ned Tijdschr Geneeskd; 1983 Jan; 127(2):41-3. PubMed ID: 6338402
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapeutic hyperinsulinism induced by the use of continuous insulin infusion pumps and the artificial pancreas in diabetic patients].
    Bergua M; Levy I; Casamitjana R; Figuerola D
    Med Clin (Barc); 1983 Sep; 81(6):243-5. PubMed ID: 6358714
    [No Abstract]   [Full Text] [Related]  

  • 28. Carbohydrate, lipid and amino acid metabolism of insulin-dependent diabetic patients regulated by an artificial beta-cell unit.
    Foss MC; Vlachokosta FV; Aoki TT
    Diabetes Res; 1989 May; 11(1):1-8. PubMed ID: 2695278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical experience with optimized therapy of insulin dependent diabetes mellitus using NovoPen].
    Carta G; Borgoglio A; Borgoglio MG; Granata L; Cordera R; Adezati L
    Clin Ter; 1988 Feb; 124(4):315-20. PubMed ID: 2974343
    [No Abstract]   [Full Text] [Related]  

  • 30. Intensified insulin regimens. Should they be used in all patients with type I diabetes?
    Hollander P
    Postgrad Med; 1994 Sep; 96(3):63-8, 72. PubMed ID: 8072915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Home glucose monitoring with microcomputer.
    Huang SW
    J Singapore Paediatr Soc; 1986; 28(3-4):266-70. PubMed ID: 3298858
    [No Abstract]   [Full Text] [Related]  

  • 32. [Development of the implantable artificial endocrine pancreas].
    Shichiri M; Nishida K; Sakakida M
    Nihon Rinsho; 1997 Nov; 55 Suppl():288-92. PubMed ID: 9434482
    [No Abstract]   [Full Text] [Related]  

  • 33. Fasting and postprandial plasma glucose and peripheral insulin levels in insulin-dependent diabetes mellitus and non-insulin-dependent diabetes mellitus subjects during continuous intraperitoneal versus subcutaneous insulin delivery.
    Hermans MP; van Ypersele de Strihou M; Ketelslegers JM; Squifflet JP; Buysschaert M
    Transplant Proc; 1995 Dec; 27(6):3329-30. PubMed ID: 8539974
    [No Abstract]   [Full Text] [Related]  

  • 34. [Recommendations for insulin treatment with a portable insulin pump].
    Gutniak M; Johansson BL; Lager I; Lins PE; Nilsson A; Reichard P; Ostman J
    Lakartidningen; 1984 Nov; 81(48):4507-10. PubMed ID: 6521559
    [No Abstract]   [Full Text] [Related]  

  • 35. DM programming moves from the Internet to mobile phones for added impact.
    Dis Manag Advis; 2007 Jul; 13(7):73-6. PubMed ID: 17713239
    [No Abstract]   [Full Text] [Related]  

  • 36. A fuzzy logic based closed-loop control system for blood glucose level regulation in diabetics.
    Ibbini MS; Masadeh MA
    J Med Eng Technol; 2005; 29(2):64-9. PubMed ID: 15804854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The importance of strict control of blood glucose at the onset and during the remission stage in newly diagnosed diabetic children].
    Vavrinec J; Lébl J; Zizkovský V; Dvorák P; Snajderová M
    Cesk Pediatr; 1988 May; 43(5):325-8. PubMed ID: 3042170
    [No Abstract]   [Full Text] [Related]  

  • 38. [Optimum therapy of insulin-dependent diabetes mellitus].
    Sinagra D
    Recenti Prog Med; 1984 Sep; 75(9):823-32. PubMed ID: 6393244
    [No Abstract]   [Full Text] [Related]  

  • 39. [Type I diabetes mellitus: insulin treatment].
    Ryff AS; Berger W; Crausaz F
    Schweiz Med Wochenschr Suppl; 1994; 60():7-13. PubMed ID: 8016617
    [No Abstract]   [Full Text] [Related]  

  • 40. Developmental and application of insulin infusion profiles for therapy of type-I diabetics with portable insulin infusion systems.
    Schulz G; Strack T; Beyer J; Krause U; Cordes U; Weber T; Nagel J; Beutelspacher F
    Life Support Syst; 1984; 2(3):189-200. PubMed ID: 6503348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.